id: NEW:resistant_starch_type_2_intake_to_NEW:insulin_sensitivity
name: Resistant Starch Type 2 Intake â†’ Insulin Sensitivity
from_node:
  node_id: NEW:resistant_starch_type_2_intake
  node_name: Resistant Starch Type 2 Intake
to_node:
  node_id: NEW:insulin_sensitivity
  node_name: Insulin Sensitivity
direction: positive
category: biological
mechanism_pathway:
- 'Step 1: Resistant starch type 2 (RS2), characterized by high amylose concentration,
  escapes digestion by endogenous enzymes in the small intestine'
- 'Step 2: RS2 reaches the large intestine where it undergoes fermentation by gut
  microbiota, producing short-chain fatty acids (SCFAs)'
- 'Step 3: SCFAs and reduced glucose absorption lead to improved acute postprandial
  insulin response and lower insulin demands'
- 'Step 4: Chronic RS2 intake results in sustained improvements in fasting insulin
  levels and fasting glucose concentrations'
- 'Step 5: Reduced insulin secretion requirements and improved glucose homeostasis
  indicate enhanced peripheral insulin sensitivity'
evidence:
  quality_rating: A
  n_studies: 36
  primary_citation: 'Jennifer E. Pugh et al. 2023. A comparison of the effects of
    resistant starch types on glycemic response in individuals with type 2 diabetes
    or prediabetes: A systematic review and meta-analysis. Frontiers in Nutrition.'
  supporting_citations: []
description: 'Resistant starch type 2 improves insulin sensitivity through multiple
  mechanisms. RS2 escapes small intestinal digestion due to its high amylose content,
  reducing acute glucose absorption and postprandial insulin demands. In chronic intake,
  RS2 significantly improves fasting insulin (SMD: -0.40) and fasting glucose (SMD:
  -0.39), indicating enhanced insulin sensitivity. The meta-analysis of 36 RCTs (n=982)
  demonstrates that RS2 also improves acute postprandial insulin response (SMD: -0.71),
  suggesting both immediate and sustained benefits for glucose homeostasis in individuals
  with T2D or prediabetes.'
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: -0.4
    type: standardized_mean_difference
    ci_lower: -0.6
    ci_upper: -0.21
  p_value: null
  sample_size: 982
moderators:
- name: diabetes_status
  direction: strengthens
  strength: moderate
  description: Sub-group analyses conducted between subjects with T2D versus prediabetes
    showed differential effects
- name: study_duration
  direction: strengthens
  strength: moderate
  description: Chronic RS2 intake showed improvements in both fasting glucose and
    fasting insulin, while acute studies showed postprandial improvements
